197 related articles for article (PubMed ID: 31817163)
21. Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells.
Tibullo D; Barbagallo I; Giallongo C; Vanella L; Conticello C; Romano A; Saccone S; Godos J; Di Raimondo F; Li Volti G
Oncotarget; 2016 May; 7(20):28868-80. PubMed ID: 26930712
[TBL] [Abstract][Full Text] [Related]
22. Proteasomal dysfunction and ER stress triggers 2'-hydroxy-retrochalcone-induced paraptosis in cancer cells.
Nedungadi D; Binoy A; Pandurangan N; Nair BG; Mishra N
Cell Biol Int; 2021 Jan; 45(1):164-176. PubMed ID: 33049087
[TBL] [Abstract][Full Text] [Related]
23. Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines.
Miyahara K; Kazama H; Kokuba H; Komatsu S; Hirota A; Takemura J; Hirasawa K; Moriya S; Abe A; Hiramoto M; Ishikawa T; Miyazawa K
Int J Oncol; 2016 Nov; 49(5):1848-1858. PubMed ID: 27601063
[TBL] [Abstract][Full Text] [Related]
24. Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma.
Yoshida T; Ri M; Kinoshita S; Narita T; Totani H; Ashour R; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S
PLoS One; 2018; 13(5):e0196780. PubMed ID: 29738534
[TBL] [Abstract][Full Text] [Related]
25. Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress‑mediated cell death in multiple myeloma cells.
Moriya S; Komatsu S; Yamasaki K; Kawai Y; Kokuba H; Hirota A; Che XF; Inazu M; Gotoh A; Hiramoto M; Miyazawa K
Int J Oncol; 2015 Feb; 46(2):474-86. PubMed ID: 25422130
[TBL] [Abstract][Full Text] [Related]
26. Ca
Raimondi M; Fontana F; Marzagalli M; Audano M; Beretta G; Procacci P; Sartori P; Mitro N; Limonta P
Apoptosis; 2021 Jun; 26(5-6):277-292. PubMed ID: 33811561
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous mitochondrial Ca(2+) overload and proteasomal inhibition are responsible for the induction of paraptosis in malignant breast cancer cells.
Yoon MJ; Kim EH; Kwon TK; Park SA; Choi KS
Cancer Lett; 2012 Nov; 324(2):197-209. PubMed ID: 22634500
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic enhancement of ER stress by insulin-like growth factor I sensitizes myeloma cells to proteasomal inhibitors.
Tagoug I; Jordheim LP; Herveau S; Matera EL; Huber AL; Chettab K; Manié S; Dumontet C
Clin Cancer Res; 2013 Jul; 19(13):3556-66. PubMed ID: 23674497
[TBL] [Abstract][Full Text] [Related]
29. Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma.
Brünnert D; Kraus M; Stühmer T; Kirner S; Heiden R; Goyal P; Driessen C; Bargou RC; Chatterjee M
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1666-1676. PubMed ID: 30954557
[TBL] [Abstract][Full Text] [Related]
30. Silver nanoparticles induce SH-SY5Y cell apoptosis via endoplasmic reticulum- and mitochondrial pathways that lengthen endoplasmic reticulum-mitochondria contact sites and alter inositol-3-phosphate receptor function.
Li L; Cui J; Liu Z; Zhou X; Li Z; Yu Y; Jia Y; Zuo D; Wu Y
Toxicol Lett; 2018 Mar; 285():156-167. PubMed ID: 29306025
[TBL] [Abstract][Full Text] [Related]
31. EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism.
Modernelli A; Naponelli V; Giovanna Troglio M; Bonacini M; Ramazzina I; Bettuzzi S; Rizzi F
Sci Rep; 2015 Oct; 5():15270. PubMed ID: 26471237
[TBL] [Abstract][Full Text] [Related]
32. Intracellular Ca
Kim E; Lee DM; Seo MJ; Lee HJ; Choi KS
Front Cell Dev Biol; 2020; 8():607844. PubMed ID: 33585447
[TBL] [Abstract][Full Text] [Related]
33. Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis.
Xu Y; Wang C; Su J; Xie Q; Ma L; Zeng L; Yu Y; Liu S; Li S; Li Z; Sun L
Oncol Rep; 2015 Dec; 34(6):3051-60. PubMed ID: 26398138
[TBL] [Abstract][Full Text] [Related]
34. Vitamin B
Solovieva M; Shatalin Y; Fadeev R; Krestinina O; Baburina Y; Kruglov A; Kharechkina E; Kobyakova M; Rogachevsky V; Shishkova E; Akatov AV
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31906414
[TBL] [Abstract][Full Text] [Related]
35. Endoplasmic reticulum stress and autophagy participate in apoptosis induced by bortezomib in cervical cancer cells.
Zhang Y; Bai C; Lu D; Wu X; Gao L; Zhang W
Biotechnol Lett; 2016 Feb; 38(2):357-65. PubMed ID: 26423802
[TBL] [Abstract][Full Text] [Related]
36. Co-inhibition of BET and proteasome enhances ER stress and Bim-dependent apoptosis with augmented cancer therapeutic efficacy.
Qian G; Yao W; Zhang S; Bajpai R; Hall WD; Shanmugam M; Lonial S; Sun SY
Cancer Lett; 2018 Oct; 435():44-54. PubMed ID: 30059709
[TBL] [Abstract][Full Text] [Related]
37. Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.
Wada N; Kawano Y; Fujiwara S; Kikukawa Y; Okuno Y; Tasaki M; Ueda M; Ando Y; Yoshinaga K; Ri M; Iida S; Nakashima T; Shiotsu Y; Mitsuya H; Hata H
Int J Oncol; 2015 Mar; 46(3):963-72. PubMed ID: 25530098
[TBL] [Abstract][Full Text] [Related]
38. The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells.
Kraus M; Bader J; Geurink PP; Weyburne ES; Mirabella AC; Silzle T; Shabaneh TB; van der Linden WA; de Bruin G; Haile SR; van Rooden E; Appenzeller C; Li N; Kisselev AF; Overkleeft H; Driessen C
Haematologica; 2015 Oct; 100(10):1350-60. PubMed ID: 26069288
[TBL] [Abstract][Full Text] [Related]
39. Plumbagin induces paraptosis in cancer cells by disrupting the sulfhydryl homeostasis and proteasomal function.
Binoy A; Nedungadi D; Katiyar N; Bose C; Shankarappa SA; Nair BG; Mishra N
Chem Biol Interact; 2019 Sep; 310():108733. PubMed ID: 31276663
[TBL] [Abstract][Full Text] [Related]
40. The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma.
Besse L; Kraus M; Besse A; Driessen C; Tarantino I
Sci Rep; 2023 Mar; 13(1):4411. PubMed ID: 36932175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
